Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 J&J 1Q08 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

J&J 1Q08

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

J&J 1Q08

1Q Revenues: $16.2 billion (+8%)

1Q Earnings: $3.6 billion (+22%)

Comments: Pharmaceutical sales rose 3% to $6.4 billion, hurt by regulatory and safety issues for Procrit, as well as generic competition for Risperdal, Duragesic and Aciphex. U.S. pharma sales were up 1% to $4.1 billion, while international sales, aided in part by currency rates, were up 8% to $2.4 billion. Global sales of Remicade grew 37% to $1.0 billion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters